Collagenase injections: A non-surgical modality in treating Dupuytren's Disease
Injectable collagenase Clostridium histolyticum: A new nonsurgical treatment for Dupuytren's diseaseJournal of Hand Surgery American; 2010; 35(A); 2027-2038
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
66 patients with contractures, affecting either the metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joints, were randomized to receive Xiaflex (collagenase clostridium histolyticum) or placebo local injection. The results of the 9-month long trial indicated that patients who received Xiaflex displayed significantly greater range of motion and a significantly decreased degree of joint c...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue